Sinobioway Medicine(SZ:002581) Zheng Quan Zhi Xing·2025-08-15 16:24Meeting Details - The meeting was held on August 15, 2025, at 2:30 PM, with online voting available from 9:15 AM to 3:00 PM on the same day [1] - A total of 323 shareholders participated, representing 143,261,055 shares, which is 21.7149% of the total voting shares [1] Shareholder Participation - Among the participants, 9 shareholders voted in person, representing 135,985,362 shares (20.6121% of total voting shares), while 314 shareholders voted online, representing 7,275,693 shares (1.1028% of total voting shares) [2][3] Proposal Voting Results - Proposal 1: Amendment to the Articles of Association - Votes in favor: 140,196,722 shares (97.8610%) - Votes against: 3,022,233 shares (2.1096%) - Abstentions: 0.0294% [2] - Proposal 2: Amendment to the Rules of Procedure for Shareholders' Meetings - Votes in favor: 139,565,062 shares (97.4201%) - Votes against: 3,653,893 shares (2.5505%) - Abstentions: 0.0294% [3][4] - Proposal 3: Amendment to the Rules of Procedure for Board Meetings - Votes in favor: 139,565,262 shares (97.4202%) - Votes against: 3,653,693 shares (2.5504%) - Abstentions: 0.0294% [4] - Proposal 4: Amendment to the Independent Director Work Rules - Votes in favor: 139,565,762 shares (97.4206%) - Votes against: 3,653,693 shares (2.5504%) - Abstentions: 0.0290% [5] - Proposal 5: Establishment of the Senior Management Compensation System - Votes in favor: 140,125,922 shares (97.8116%) - Votes against: 3,065,033 shares (2.1395%) - Abstentions: 0.0489% [5] - Proposal 6: Sixth Board Compensation Plan - Votes in favor: 140,122,122 shares (97.8089%) - Votes against: 3,069,333 shares (2.1425%) - Abstentions: 0.0486% [6] Legal Opinion - The legal opinion confirmed that the qualifications of the attendees and the voting procedures complied with legal and regulatory requirements, making the voting results valid [6]